Job DescriptionDESCRIPTION MAIN INTERACTIONS KEY RESPONSIBILITIES & DECISIONS
- Enables commercialisation by enabling positive reimbursement/ HTA decisions which drive product listing and optimal pricing
- Manages HTA readiness and execution by leading development and communication of core HTA strategy, ensuring EU consistency
- Leads disease and health economic modelling, from strategy and design, through building, validation and vendor management, to presentation and publication
- Manages delivery of core European HEOR materials and supports European affiliate adaptations
- Co-ordinates alignment with Global and other regional (e.g. US, Canada, Asia-Pacific) HTA/HE strategy, as well as aligning with Business Unit and Alliance Partner strategies
- Supports the timely and appropriate engagement of formal HTA Scientific Advice in key European countries, and manages relevant cross-functional teams to ensure advice is high quality and well understood
- Collaborates with the Global Real World Evidence and Value team to develop and deliver key evidence to meet HTA requirements and contribute to value messaging
- Working in, and managing, complex cross functional matrix teams, to develop strategies that proactively shape HTA preparation and delivery as well as supporting mature product life cycles
KEY RESPONSIBILITIESS & DECISIONS
- Manages the development, implementation and communication of core European HTA submission strategy
- Provides flexible support to affiliate teams throughout the HTA process in dossier development and evidence synthesis, as well as co-chairing HTA sub teams
- Provides full life-cycle HE/HTA expertise from Business Development and early pipeline support, through early phase development and pre-launch preparations to in-market and mature product support
- Seeks external scientific advice (both formal or informal) to inform and solidify HTA strategy and requirements, as well as wider therapy area planning (e.g. Evidence generation and reimbursement potential)
- Manages the development of core European disease and pharmaco- economic modelling projects
- Ensures high quality health economic arguments are available for mature products
- Contributes strategy, advice and expertise to the development of value messages and dossiers
- Contributes cross-country best practice/ strategy sharing
- Manages HTA/HE budget efficiently
LEADERSHIP & BEHAVIOURAL COMPETENCIES FOR THIS POSITION ARE:
- Excellent matrix leadership and collaboration
- Partnership working
- Planning and execution
- Effective and influential written and verbal communication
- Influencing skills
- Provide supportive challenge to senior internal and external stakeholders
- Strong communication and interpersonal skills, written and verbal
- Ability to influence complex networks Technical health economic understanding
- Collaborative working
- Communication
- Influencing
- Stakeholder management (internal and external)
FUNCTIONAL & TECHNICAL COMPETENCIES FOR THIS POSITION ARE:
- Strong working knowledge of Health Economic methods and economic evaluation
- Ability to confidently execute across the product life-cycle with minimal support
- Working knowledge of the processes of key European HTA/reimbursement systems
- Commercial acumen with ability to convey the impact of HTA to the business
- Strategic thinking and implementation
- Critical thinking, analysis and problem solving
- HTA strategy and execution
- Pan-EU strategy
- Matrix working
- Strategic analysis
- Budgeting
- Outcomes Research
- Clinical trial and statistical analysis appreciation for HTA
- Brand strategy
- Pipeline strategy
ACTIVITIES FOCUS
HTA Execution – 35%
Health Economic Delivery – 35%
HTA & Access strategy development – 10%
Lifecycle Management – 5%
Early Phase Strategy – 5%
Cross Functional Strategy and Alignment – 10%
QUALIFICATIONS/ EXPERIENCE
- A postgraduate qualification in Health Economics, Economic Evaluation or similar discipline
- Appropriate prior industry experience, ideally including:
- An understanding of pharmaco-economic modelling and economic evaluation
- An understanding of best practice in literature reviewing and indirect comparison methodologies
- An understanding of the processes of European HTA
- An appreciation of the role of health economics for assets at all phases of drug development